Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMARIN CORP PLC\UKAMRN · Entity 5970 | EVP, Chief Scientific Officer | July 01, 2026 | July 15, 2026 |
| Viracta Therapeutics, Inc.SNSS · Entity 85616 | Director | June 30, 2020 | July 01, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMARIN CORP PLC\UK
Report date July 01, 2026 · Filed July 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 42,680 |
Last balance in matching sequence
After 2026-07-01 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-07-01 · Exercise / conversion · Acquired 3,688 · Balance 44,567 F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F3: Not applicable. Row 2 · 2026-07-01 · Tax withholding · Disposed 1,887 · Balance 42,680 F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-01 · Grant · Acquired 3,688 · Balance 0 F5: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F3: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change.
F2: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026.
F3: Not applicable.
F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
F5: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion.
Viracta Therapeutics, Inc.
Report date June 30, 2020 · Filed July 01, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.26 · Expires 2030-06-30 | Direct | 60,000 |
Reported balance
After 2020-06-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-30 · Grant · Acquired 60,000 · Balance 60,000 F1: The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 15, 2026 21:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Unit · Derivative | 3,688 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-304911 · ownership.xml · derivative · entry 3 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: American Depositary Shares · 3,688 shares Expires not disclosed F5 · security: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · derivative.exercise_date: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · derivative.underlying_shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| July 01, 2026 Filed Jul 15, 2026 21:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingAmerican Depositary Shares | 1,887 | $15.94 | $30,078.78 |
DisclosureSEC source: 0001193125-26-304911 · ownership.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,680 F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| July 01, 2026 Filed Jul 15, 2026 21:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionAmerican Depositary Shares | 3,688 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-304911 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · kind: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F3 · price: Not applicable. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 00:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 36,060 | $0.00 Strike: $14.99 | $0.00 |
DisclosureSEC source: 0001193125-26-036169 · ownership.xml · derivative · entry 8 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,060 Underlying: American Depositary Shares · 36,060 shares Expires 2036-02-01 F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F8 · derivative.exercise_date: On February 1, 2026, the Reporting Person was granted an option to purchase 36,060 ADSs under the Plan. The shares subject to this option shall vest and become exercisable over three years, with 33% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 8 calendar quarters on the first day of each May, August, November and February. F1 · derivative.underlying: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · derivative.underlying_shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 00:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Unit · Derivative | 8,013 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-036169 · ownership.xml · derivative · entry 7 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: American Depositary Shares · 8,013 shares Expires not disclosed F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F7 · derivative.exercise_date: On February 1, 2026, the Reporting Person was granted 8,013 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2027, January 31, 2028 and January 31, 2029. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · derivative.underlying_shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 1,933 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-036169 · ownership.xml · derivative · entry 6 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,933 Underlying: American Depositary Shares · 1,933 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F5 · derivative.exercise_date: On February 1, 2024, the Reporting Person was granted 5,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026 and January 31, 2027. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · derivative.underlying_shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 2,246 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-036169 · ownership.xml · derivative · entry 5 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: American Depositary Shares · 2,246 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 6,740 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · derivative.underlying_shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingAmerican Depositary Shares | 1,062 | $15.42 | $16,376.04 |
DisclosureSEC source: 0001193125-26-036169 · ownership.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,879 F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionAmerican Depositary Shares | 1,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-036169 · ownership.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F5 · kind: On February 1, 2024, the Reporting Person was granted 5,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026 and January 31, 2027. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F3 · price: Not applicable. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingAmerican Depositary Shares | 1,235 | $15.42 | $19,043.70 |
DisclosureSEC source: 0001193125-26-036169 · ownership.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,008 F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 00:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionAmerican Depositary Shares | 2,246 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-036169 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · kind: On February 21, 2023, the Reporting Person was granted 6,740 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F3 · price: Not applicable. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Unit · Derivative | 3,688 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-004718 · ownership.xml · derivative · entry 3 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,688 Underlying: American Depositary Shares · 3,688 shares Expires not disclosed F5 · security: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · derivative.exercise_date: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · derivative.underlying_shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingAmerican Depositary Shares | 2,041 | $13.96 | $28,492.36 |
DisclosureSEC source: 0001193125-26-004718 · ownership.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,997 F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionAmerican Depositary Shares | 3,688 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-004718 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2 · kind: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F1 · shares: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F3 · price: Not applicable. F1 · balance_after: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. Read SEC document |
| January 31, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 38,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · derivative · entry 13 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,333 Underlying: Ordinary Shares · 38,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F8 · derivative.exercise_date: On February 1, 2024, the Reporting Person was granted 116,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026 and January 31, 2027. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 44,933 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · derivative · entry 12 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,934 Underlying: Ordinary Shares · 44,933 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F7 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 134,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 34,566 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · derivative · entry 11 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 34,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F6 · derivative.exercise_date: On February 4, 2022, the Reporting Person was granted 103,700 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (as amended, the "Plan"). These RSUs vest in three equal installments on each of January 31, 2023, January 31, 2024 and January 31, 2025. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 21,093 | $0.62 | $13,077.66 |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · nonDerivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 747,001 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F5 · price: Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day. Read SEC document |
| January 31, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 38,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · nonDerivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 768,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F8 · kind: On February 1, 2024, the Reporting Person was granted 116,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026 and January 31, 2027. F3 · price: Not applicable Read SEC document |
| January 31, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 24,833 | $0.62 | $15,396.46 |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · nonDerivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 729,427 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F5 · price: Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day. Read SEC document |
| January 31, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 44,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · nonDerivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 754,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · kind: On February 21, 2023, the Reporting Person was granted 134,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. F3 · price: Not applicable Read SEC document |
| January 31, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 19,197 | $0.62 | $11,902.14 |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 709,327 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F5 · price: Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day. Read SEC document |
| January 31, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 34,566 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 728,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · kind: On February 4, 2022, the Reporting Person was granted 103,700 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (as amended, the "Plan"). These RSUs vest in three equal installments on each of January 31, 2023, January 31, 2024 and January 31, 2025. F3 · price: Not applicable Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 51,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · derivative · entry 10 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 51,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 30, 2025, the second of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Unit · Derivative | 51,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · derivative · entry 9 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 51,500 shares Expires not disclosed F9 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 30, 2025, the second of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 28,382 | $0.62 | $17,596.84 |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 693,958 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F5 · price: Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:45 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 51,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-011824 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 722,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 30, 2025, the second of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. F3 · price: Not applicable Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 22:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 663,878 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0000950170-25-004275 · ownership.xml · derivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 663,878 Underlying: Ordinary Shares · 663,878 shares Expires 2035-01-10 F1 · derivative.exercise_price: Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day. F2 · derivative.exercise_date: On January 10, 2025, the Reporting Person was granted an option to purchase 663,878 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable over eighteen months, with 50% to vest on the first anniversary of the grant date and the remaining balance to vest eighteen months after grant date. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 20:54 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 11,763 | $0.78 | $9,175.14 |
DisclosureSEC source: 0000950170-24-089392 · ownership.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 670,840 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 20:54 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 23,883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-089392 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 682,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On August 2, 2021, the Reporting Person was granted 71,650 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. These RSUs vest in three equal installments on each of July 31, 2022, July 31, 2023 and July 31, 2024. F3 · price: Not applicable Read SEC document |
| February 01, 2024 Filed Feb 9, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 418,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0000950170-24-013290 · ownership.xml · derivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,000 Underlying: Ordinary Shares · 418,000 shares Expires 2034-02-01 F5 · derivative.exercise_date: On February 1, 2024, the Reporting Person was granted an option to purchase 418,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable over three years, with 33% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each April, July, October and January. F4 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 01, 2024 Filed Feb 9, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Unit · Derivative | 116,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-013290 · ownership.xml · derivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,000 Underlying: Ordinary Shares · 116,000 shares Expires not disclosed F1 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 1, 2024, the Reporting Person was granted 116,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026 and January 31, 2027. F3 · derivative.expiration_date: Not applicable F4 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 44,933 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010535 · ownership.xml · derivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,867 Underlying: Ordinary Shares · 44,933 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F5 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 134,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 34,567 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010535 · ownership.xml · derivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,566 Underlying: Ordinary Shares · 34,567 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 4, 2022, the Reporting Person was granted 103,700 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (as amended, the "Plan"). These RSUs vest in three equal installments on each of January 31, 2023, January 31, 2024 and January 31, 2025. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 22,316 | $1.24 | $27,671.84 |
DisclosureSEC source: 0000950170-24-010535 · ownership.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 658,720 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 44,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010535 · ownership.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 681,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · kind: On February 21, 2023, the Reporting Person was granted 134,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. F3 · price: Not applicable Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 18,871 | $1.24 | $23,400.04 |
DisclosureSEC source: 0000950170-24-010535 · ownership.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 636,103 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 34,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010535 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 654,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On February 4, 2022, the Reporting Person was granted 103,700 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (as amended, the "Plan"). These RSUs vest in three equal installments on each of January 31, 2023, January 31, 2024 and January 31, 2025. F3 · price: Not applicable Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:31 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 51,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-004308 · ownership.xml · derivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 51,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 10, 2024, the first of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:31 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Unit · Derivative | 51,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-004308 · ownership.xml · derivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 51,500 shares Expires not disclosed F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 10, 2024, the first of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:31 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 28,270 | $0.97 | $27,421.90 |
DisclosureSEC source: 0000950170-24-004308 · ownership.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 620,407 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:31 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 51,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-004308 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 648,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 10, 2024, the first of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. F3 · price: Not applicable Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 23:03 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 14,566 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003082 · ownership.xml · derivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents the third and final time-based vesting event under the previously disclosed performance-based restricted stock unit ("RSU") award granted to the Reporting Person on January 4, 2021, which was subject to both performance and time-based vesting. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 23:03 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 7,730 | $0.87 | $6,725.10 |
DisclosureSEC source: 0000950170-24-003082 · ownership.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 597,177 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 23:03 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 14,566 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-003082 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: Represents the third and final time-based vesting event under the previously disclosed performance-based restricted stock unit ("RSU") award granted to the Reporting Person on January 4, 2021, which was subject to both performance and time-based vesting. F3 · price: Not applicable Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:47 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 47,766 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000322 · ownership.xml · derivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,766 Underlying: Ordinary Shares · 47,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On January 4, 2021, the Reporting Person was granted 143,300 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan"). These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023. As the final vesting date fell on a weekend, the second vesting event occurred on December 29, 2023, the previous business day. F3 · derivative.expiration_date: Not applicable Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:47 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 23,525 | $0.87 | $20,466.75 |
DisclosureSEC source: 0000950170-24-000322 · ownership.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 590,341 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:47 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 47,766 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000322 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 613,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On January 4, 2021, the Reporting Person was granted 143,300 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan"). These RSUs vest in three equal installments on each of December 31, 2021, December 31, 2022 and December 31, 2023. As the final vesting date fell on a weekend, the second vesting event occurred on December 29, 2023, the previous business day. F3 · price: Not applicable Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 23:35 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 34,131 | $0.79 | $26,963.49 |
DisclosureSEC source: 0000950170-23-070510 · ownership.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 566,100 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2023. F3 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.78 to $0.8055, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 21:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 23,883 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-037291 · ownership.xml · derivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,883 Underlying: Ordinary Shares · 23,883 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On August 2, 2021, the Reporting Person was granted 71,650 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan. These RSUs vest in three equal installments on each of July 31, 2022, July 31, 2023 and July 31, 2024. F3 · derivative.expiration_date: Not applicable Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.